BSEM
BSEM clinical trials: BioStem Technologies, Inc.
Every trial on ClinicalTrials.gov where BioStem Technologies, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BSEM on the catalyst calendar · BSEM registry changes
- Primary completion Aug 14, 2026ActualNo phase registeredNCT06811909Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-ACBioStem Technologies · Non-infected Venous Leg UlcerCompletedBSEMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2024Sponsor estimateNo phase registeredNCT06150209A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.BioStem Technologies · Diabetic Foot UlcerWithdrawnBSEMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 14, 2025ActualNo phase registeredNCT06565156Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AMBioStem Technologies · Non-infected Diabetic Foot UlcerCompletedBSEMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 5, 2025ActualNo phase registeredNCT06511596A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-ACBioStem Technologies · Diabetic Foot UlcerCompletedBSEMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner